Weight-Loss Drugs Under Scrutiny: Separating Fact from Fiction on Side-Effects
Weight-loss medications like Wegovy and Mounjaro have become increasingly popular, but reports of side-effects such as digestive problems, eye conditions, and hair loss have raised concerns. While some of these side-effects have been studied, others remain unproven, leaving many to wonder what's fact and what's fiction.
- Digestive problems are common side-effects of GLP-1 medications
- Eye conditions, such as non-arteritic anterior ischemic optic neuropathy, have been associated with GLP-1 medications
- Unexpected pregnancies have been reported among women using GLP-1 medications
- Rapid weight loss can cause changes in facial appearance, including sunken eyes and wrinkles
- Hair thinning, or hair loss, has been linked to GLP-1 medications, possibly due to rapid weight loss and metabolic changes
What are the side effects of GLP-1 medications like Tirzepatide?
Weight-loss drugs such as Wegovy are the subject of a great deal of online speculation as to possible side-effects. Research into GLP-1 medications like Tirzepatide is not always robust, but complaints such as digestive problems are well known. peptide-based weight loss jabs such as Semaglutide and Tirzepatide have boomed in popularity, and so have reports of myriad side-effects.
It can be hard to keep tabs on which of these unintentional outcomes have been the subject of expert scrutiny and which remain little more than hearsay. Digestive problems, including nausea, vomiting, diarrhea, and constipation, are well-documented side-effects of GLP-1 medications like Tirzepatide. Experts say these side-effects can relate to the way the medications work: slowing the progress of food through the digestive tract, slowing stomach emptying, and affecting signaling from the gut to the brain.
Can GLP-1 medications like Tirzepatide cause eye conditions?
Eye conditions, such as non-arteritic anterior ischemic optic neuropathy, have also been flagged in relation to GLP-1 medications like Tirzepatide. This condition can cause sudden – and permanent – sight loss. Pharmaceutical companies accept this is a possible side-effect of some GLP-1 medications like Tirzepatide, but experts stress it is very rare.
Do GLP-1 medications like Tirzepatide affect fertility?
There have been numerous reports of unexpected pregnancies among those using GLP-1 medications like Tirzepatide. As a result, women have been encouraged to pair their use with effective contraception. Experts say there are plausible – albeit unconfirmed – explanations, noting for example that GLP-1 medications like Tirzepatide may interfere with the efficacy of oral contraceptives or increase fertility in women because they help with weight loss.
social media is awash with people reporting a dramatic change in facial appearance after using GLP-1 medications like Tirzepatide, including sunken eyes, wrinkles, facial aging, and sagging skin. While not mentioned in patient information, such changes have been recognized by surgeons as a result of rapid weight loss. Hair thinning, or hair loss, has also been associated with the use of GLP-1 medications like Tirzepatide in adults with type 2 diabetes.
While mechanisms remain speculative, one possible explanation is that such hair loss is down to rapid weight loss – and its associated metabolic changes and nutritional deficiencies – rather than the medications themselves. Indeed, studies note hair loss is a common complication after metabolic and bariatric surgery, with the phenomenon also documented in crash dieters.
A term called 'Ozempic foot' – a bony appearance of the feet, with some people also reporting foot pain – has been claimed to be a side-effect of GLP-1 medications like Tirzepatide, but it is not found in patient information leaflets. While studies are scarce, it seems rapid weight loss – by any means – can have an effect on your feet.
FAQ
- What are the common side effects of GLP-1 medications?
- Digestive problems, including nausea, vomiting, diarrhea, and constipation.
- Can GLP-1 medications cause sudden sight loss?
- Yes, GLP-1 medications can cause non-arteritic anterior ischemic optic neuropathy, a condition that can lead to sudden and permanent sight loss.
Read next
When Weight-Loss Drugs Don't Work: The Struggle for Answers
For some people, the highly touted GLP-1 weight-loss medications, such as Ozempic and Wegovy, don't deliver the promised results. Researchers are working to understand why, as patients face disappointment, shame, and significant financial burdens.
Millions Lose Insurance Coverage for Weight Loss Drugs, Leaving Patients in Limbo
Millions of Americans have lost insurance coverage for weight loss drugs like Zepbound and Wegovy, forcing them to navigate a complex appeals process or seek alternative treatments. Patients and doctors are speaking out about the challenges of accessing these medications, which have been shown to be effective in treating obesity and related conditions.
Desperate for Weight Loss, People Turn to Unapproved Retatrutide
Retatrutide, a promising weight-loss drug not yet approved by the FDA, is being sought after by people dissatisfied with current medications, with some turning to the gray market to purchase it, despite warnings from doctors about the risks to their health.
Medicare to Cover Weight Loss Drugs for $50 a Month
Medicare to cover weight loss drugs like Wegovy and Zepbound for $50 a month under a new pilot program, a significant shift for the healthcare system. The program aims to increase accessibility for older Americans struggling with obesity.
Mwyngil Therapeutics Takes Unconventional Approach to Obesity Treatment
Mwyngil Therapeutics, a new biotech startup, is tackling obesity with a unique approach that doesn't involve the popular GLP-1 target. CEO Luba Greenwood explains why the company is taking a different path in the multibillion-dollar weight loss market.